3B Blackbio Dx Limited (NSE:3BBLACKBIO)
India · Delayed Price · Currency is INR 1,293.60
+17.70 (1.39%)
At close: Nov 9, 2026
3B Blackbio Dx Market Cap
3B Blackbio Dx has a market cap or net worth of 11.06 billion as of November 10, 2026. Its market cap has decreased by 2.91% in one year.
Market Cap
11.06B
Enterprise Value
10.15B
Revenue
1.53B
Global Rank
n/a
Country Rank
n/a
PE Ratio
19.84
ChartMarket Cap Chart
Since April 10, 2008, 3B Blackbio Dx's market cap has increased from 100.83M to 11.06B, an increase of 10,866.69%. That is a compound annual growth rate of 28.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 9, 2026 | 11.06B | -8.15% |
| Dec 31, 2025 | 12.04B | -28.99% |
| Dec 31, 2024 | 16.95B | 150.19% |
| Dec 29, 2023 | 6.78B | 93.81% |
| Dec 30, 2022 | 3.50B | 4.44% |
| Dec 31, 2021 | 3.35B | 26.17% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biocon | 605.89B |
| Anthem Biosciences | 545.76B |
| OneSource Specialty Pharma | 188.28B |
| Concord Biotech | 125.90B |
| Blue Jet Healthcare | 105.57B |
| Supriya Lifescience | 48.71B |
| Zota Health Care | 42.70B |
| Dishman Carbogen Amcis | 24.55B |